Home > Financial Ratios > CAPLIN POINT LABORATORIES

CAPLIN POINT LABORATORIES
EV/Core EBITDA

    Back to All Ratios
CAPLIN POINT LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CAPLIN POINT LABORATORIES
Please provide your vote to see the results

CAPLIN POINT LABORATORIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 15.418.2811.007.706.71

What is the latest EV/Core EBITDA ratio of CAPLIN POINT LABORATORIES ?

The latest EV/Core EBITDA ratio of CAPLIN POINT LABORATORIES is 15.41 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202415.41
Mar20238.28
Mar202211.00
Mar20217.70
Mar20206.71

How is EV/Core EBITDA of CAPLIN POINT LABORATORIES Trending?

Years EV/Core EBITDA % Change
Mar2024 15.41
86.11
Mar2023 8.28
-24.73
Mar2022 11
42.86
Mar2021 7.7
14.75
Mar2020 6.71 -

Other Financial Ratios of CAPLIN POINT LABORATORIES


Compare EV/Core EBITDA ratio of peers of CAPLIN POINT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CAPLIN POINT LABORATORIES ₹15,722.5 Cr 1.6% 4.3% 38% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,219.0 Cr 0.4% 1.7% 2% Stock Analytics
DIVIS LABORATORIES ₹175,227.0 Cr -0.3% -3.8% 35.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,643.0 Cr 3.9% 11.8% 20% Stock Analytics
CIPLA ₹125,541.0 Cr 1.5% 3.8% 2% Stock Analytics
DR REDDYS LABORATORIES ₹106,063.0 Cr -0.5% -0.1% -5.1% Stock Analytics


CAPLIN POINT LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CAPLIN POINT LABORATORIES

1.6%

4.3%

38%

SENSEX

-1.2%

-3%

-0.2%


You may also like the below Video Courses